acquired bleeding disorder
Showing 1 - 25 of 26
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass Trial in Worldwide (catridecacog, )
Completed
- Acquired Bleeding Disorder
- Cardiac Surgery Requiring Cardiopulmonary Bypass
- catridecacog
- placebo
-
Atlanta, Georgia
- +31 more
Jan 23, 2017
Acquired Bleeding Disorder, Bleeding During/Following Surgery Trial in United States (standard therapy, , activated recombinant
Terminated
- Acquired Bleeding Disorder
- Bleeding During/Following Surgery
- standard therapy
- +2 more
-
Little Rock, Arkansas
- +6 more
Feb 23, 2017
(ID) of Safety Issues After Traumatic Brain Injury
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
-
Plainsboro, New Jersey
- +1 more
Feb 23, 2017
Acquired Bleeding Disorder, Acquired Haemophilia, Congenital Bleeding Disorder Trial in Paris (activated recombinant human
Completed
- Acquired Bleeding Disorder
- +7 more
- activated recombinant human factor VII
-
Paris, FranceNovo Nordisk Investigational Site
Jan 18, 2017
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in Worldwide (activated recombinant human factor VII)
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- activated recombinant human factor VII
-
Melbourne, Australia
- +14 more
Jan 17, 2017
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in New York (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- activated recombinant human factor VII
- placebo
-
New York, New YorkNovo Nordisk Investigational Site
Jan 12, 2017
Acquired Bleeding Disorder, Trauma Trial in London (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
- placebo
-
London, United KingdomNovo Nordisk Investigational Site
Jan 12, 2017
Acquired Bleeding Disorder, Cirrhosis Trial in China, Taiwan, Thailand (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Cirrhosis
- activated recombinant human factor VII
- placebo
-
Beijing, Beijing, China
- +6 more
Jan 12, 2017
Acquired Bleeding Disorder, Trauma Trial in Worldwide (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
- placebo
-
Perth, Australia
- +8 more
Jan 12, 2017
Acquired Bleeding Disorder, Bleeding During/Following Surgery Trial in Worldwide (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Bleeding During/Following Surgery
- activated recombinant human factor VII
- placebo
-
Camperdown, Australia
- +17 more
Jan 12, 2017
Acquired Bleeding Disorder, Spinal Fusion Trial in United States (eptacog alfa (activated))
Completed
- Acquired Bleeding Disorder
- Spinal Fusion
- eptacog alfa (activated)
-
Sacramento, California
- +13 more
Jan 12, 2017
Acquired Bleeding Disorder, Cirrhosis Trial in Worldwide (activated recombinant human factor VII)
Completed
- Acquired Bleeding Disorder
- Cirrhosis
- activated recombinant human factor VII
-
Wien, Austria
- +43 more
Jan 12, 2017
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in Worldwide (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- activated recombinant human factor VII
- placebo
-
Parkville, Victoria, Australia
- +8 more
Jan 11, 2017
Acquired Bleeding Disorder, Trauma Trial in Worldwide (activated recombinant human factor VII)
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
-
Montreal, Canada
- +14 more
Jan 11, 2017
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass Trial in Parkville (activated recombinant human
Completed
- Acquired Bleeding Disorder
- Cardiac Surgery Requiring Cardiopulmonary Bypass
- activated recombinant human factor VII
- placebo
-
Parkville, AustraliaNovo Nordisk Investigational Site
Jan 11, 2017
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass Trial in Worldwide (activated recombinant human
Terminated
- Acquired Bleeding Disorder
- Cardiac Surgery Requiring Cardiopulmonary Bypass
- activated recombinant human factor VII
-
Birmingham, Alabama
- +62 more
Jan 11, 2017
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in Worldwide (eptacog alfa (activated))
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- eptacog alfa (activated)
-
Birmingham, Alabama
- +166 more
Jan 11, 2017
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass Trial in Worldwide (catridecacog, )
Completed
- Acquired Bleeding Disorder
- Cardiac Surgery Requiring Cardiopulmonary Bypass
- catridecacog
- placebo
-
Tucson, Arizona
- +23 more
Jan 10, 2017
Acquired Bleeding Disorder, Dengue Haemorrhagic Fever Trial in Malaysia, Philippines, Thailand (activated recombinant human
Completed
- Acquired Bleeding Disorder
- Dengue Haemorrhagic Fever
- activated recombinant human factor VII
- placebo
-
Kuala Lumpur, Malaysia
- +8 more
Jan 10, 2017
Acquired Bleeding Disorder, Bleeding During/Following Surgery Trial in Worldwide (standard therapy, activated recombinant human
Completed
- Acquired Bleeding Disorder
- Bleeding During/Following Surgery
- standard therapy
- +2 more
-
Chapel Hill, North Carolina
- +45 more
Jan 10, 2017
Safety of NovoSeven® During "Real-life" Usage in Germany
Completed
- Congenital Bleeding Disorder
- +4 more
- eptacog alfa (activated)
-
Mainz, GermanyNovo Nordisk Investigational Site
Dec 6, 2016
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in Tokyo (eptacog alfa (activated))
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- eptacog alfa (activated)
-
Tokyo, JapanNovo Nordisk Investigational Site
Nov 16, 2016
Acquired Bleeding Disorder, Trauma Trial in Worldwide (eptacog alfa (activated), )
Terminated
- Acquired Bleeding Disorder
- Trauma
- eptacog alfa (activated)
- placebo
-
Princeton, New Jersey
- +13 more
Jun 13, 2014
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass, Healthy Trial in Fukuoka (catridecacog, )
Completed
- Acquired Bleeding Disorder
- +2 more
- catridecacog
- placebo
-
Fukuoka, Japan(unnamed)
Jun 17, 2014
NovoSeven® for Haemostatic Treatment of Bleeding Episodes in
Completed
- Acquired Bleeding Disorder
- Acquired Haemophilia
- activated recombinant human factor VII
-
Paris La défense cedex, France(unnamed)
Jan 29, 2014